Biomarkers in atrial fibrillation, ventricular arrhythmias, and sudden cardiac death

Stavros Mountantonakis1, Rajat Deo

  • 1Section of Electrophysiology, Division of Cardiology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Cardiovascular Therapeutics
|November 13, 2010
PubMed

Insights

Cardiac arrhythmias like atrial fibrillation can cause serious health issues. This review explores biological markers, focusing on neurohormonal, inflammatory, and metabolic pathways, to predict arrhythmia onset and complications.

Area of Science:

  • Cardiology
  • Biomedical Research
  • Translational Medicine

Background:

  • Cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, are significant contributors to cardiovascular morbidity and mortality.
  • These arrhythmias can arise from underlying structural heart disease or manifest as primary indicators of subclinical cardiovascular disease.
  • Consequences of cardiac arrhythmias include stroke, heart failure, and increased mortality.

Purpose of the Study:

  • To review clinical and translational studies identifying biological markers for predicting cardiac arrhythmias.
  • To highlight mechanisms involving the neurohormonal system, inflammation, the renin-angiotensin-aldosterone system, and metabolic pathways.
  • To inform risk stratification and diagnostic strategies for early intervention.

Main Methods:

  • Literature review of clinical and translational studies.
  • Focus on research identifying predictive biological markers for cardiac arrhythmias.
  • Analysis of mechanisms including neurohormonal, inflammatory, and metabolic pathways.

Main Results:

  • Identification of potential biological markers for predicting cardiac arrhythmia onset.
  • Emphasis on the role of the neurohormonal system, inflammation, RAAS, and metabolic pathways.
  • Insights into mechanisms underlying arrhythmia development and complications.

Conclusions:

  • Biological markers hold promise for predicting cardiac arrhythmias and their complications.
  • Understanding neurohormonal, inflammatory, and metabolic pathways is crucial for risk stratification.
  • Early identification and intervention based on these markers can mitigate adverse cardiovascular events.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...